PT98828A - Processo para a preparacao de derivados de aminoacidos ciclizados no terminal-c e de composicoes farmaceuticas que os contem - Google Patents
Processo para a preparacao de derivados de aminoacidos ciclizados no terminal-c e de composicoes farmaceuticas que os contem Download PDFInfo
- Publication number
- PT98828A PT98828A PT98828A PT9882891A PT98828A PT 98828 A PT98828 A PT 98828A PT 98828 A PT98828 A PT 98828A PT 9882891 A PT9882891 A PT 9882891A PT 98828 A PT98828 A PT 98828A
- Authority
- PT
- Portugal
- Prior art keywords
- amino
- compound
- methyl
- indol
- oxo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57629690A | 1990-08-31 | 1990-08-31 | |
| US07/726,654 US5244915A (en) | 1990-08-31 | 1991-07-12 | Amico acid derivatives cyclized at the c-terminal |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT98828A true PT98828A (pt) | 1992-07-31 |
Family
ID=27076919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98828A PT98828A (pt) | 1990-08-31 | 1991-08-30 | Processo para a preparacao de derivados de aminoacidos ciclizados no terminal-c e de composicoes farmaceuticas que os contem |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US5244915A (https=) |
| EP (1) | EP0546123A1 (https=) |
| JP (1) | JPH06502850A (https=) |
| KR (1) | KR930702296A (https=) |
| AU (1) | AU658377B2 (https=) |
| CA (1) | CA2088996A1 (https=) |
| FI (1) | FI930878L (https=) |
| IE (1) | IE913078A1 (https=) |
| NZ (1) | NZ239612A (https=) |
| PT (1) | PT98828A (https=) |
| WO (1) | WO1992004322A1 (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5631281A (en) * | 1989-06-29 | 1997-05-20 | Warner-Lambert Company | N-substituted cycloalkyl and polycycloalkyl α-substituted Trp-Phe- and phenethylamine derivatives |
| US5593967A (en) * | 1990-08-31 | 1997-01-14 | Warner-Lambert Company | Cholecystokinin antagonists, their preparation and therapeutic use |
| NZ239595A (en) * | 1990-08-31 | 1994-06-27 | Warner Lambert Co | Cholecystokinin antagonistic compounds ; pharmaceutical compositions and use thereof |
| WO1993000897A1 (en) * | 1991-07-12 | 1993-01-21 | Warner-Lambert Company | Cholecystokinin antagonists useful in the treatment of panic attacks |
| US5217957A (en) * | 1991-08-20 | 1993-06-08 | Warner-Lambert Company | Cholecystokinin antagonists useful for treating depression |
| US5380872A (en) * | 1992-07-14 | 1995-01-10 | Glaxo Inc. | Modulators of cholecystokinin |
| FR2700540B1 (fr) * | 1993-01-15 | 1995-02-17 | Irj | alpha-méthyl-(R)-tryptophyl-arylcycloalkylalkylamides ligands aux récepteurs des gastrines, leur préparation et leur utilisation en thérapeutique. |
| US6129685A (en) * | 1994-02-09 | 2000-10-10 | The University Of Iowa Research Foundation | Stereotactic hypothalamic obesity probe |
| US7077822B1 (en) | 1994-02-09 | 2006-07-18 | The University Of Iowa Research Foundation | Stereotactic hypothalamic obesity probe |
| JP3361100B2 (ja) * | 1994-03-10 | 2003-01-07 | ワーナー−ランバート・コンパニー | Cck受容体アンタゴニストとしてのインドール誘導体 |
| US5420353A (en) * | 1994-03-11 | 1995-05-30 | Merck & Co., Inc. | Regiospecific process to make cis-1-amino-2-alkanol from epoxide |
| JP2000506141A (ja) * | 1996-02-27 | 2000-05-23 | マリンクロッド・インコーポレイテッド | 標識化cck―b受容体リガンドによるヒト悪性腫瘍の検出および位置特定 |
| WO2002026104A2 (en) * | 2000-09-27 | 2002-04-04 | Niazi Sarfaraz K | A combination of appetite controlling agents which create a synergy and produce a satiating result |
| US20060062864A1 (en) * | 2000-12-28 | 2006-03-23 | Mccleary Edward L | Weight loss composition and method |
| CA2502209A1 (en) * | 2002-10-15 | 2004-04-29 | University Of Tennessee Research Foundation | Methylene-bridged selective androgen receptor modulators and methods of use thereof |
| CN101214249A (zh) * | 2003-11-25 | 2008-07-09 | 纽约大学西奈山医学院 | 尼曼-皮克病的基于陪伴分子的治疗 |
| CA2555594A1 (en) * | 2004-02-10 | 2005-08-25 | Janssen Pharmaceutica N.V. | Pyridazinones as antagonists of a4 integrins |
| US20050245534A1 (en) * | 2004-04-29 | 2005-11-03 | Link James T | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
| US7880001B2 (en) * | 2004-04-29 | 2011-02-01 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
| US8415354B2 (en) * | 2004-04-29 | 2013-04-09 | Abbott Laboratories | Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| US20050261302A1 (en) * | 2004-04-29 | 2005-11-24 | Hoff Ethan D | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their therapeutic application |
| US20100222316A1 (en) * | 2004-04-29 | 2010-09-02 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| US8198331B2 (en) * | 2005-01-05 | 2012-06-12 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| MX2007008238A (es) | 2005-01-05 | 2007-08-17 | Abbott Lab | Derivados de adamantilo como inhibidores de la enzima 11-beta-hidroxiesteroide deshidrogenasa tipo 1. |
| CN101142172A (zh) * | 2005-01-05 | 2008-03-12 | 艾博特公司 | 11-β-羟甾类脱氢酶1型酶的抑制剂 |
| US20090192198A1 (en) | 2005-01-05 | 2009-07-30 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| JP5736098B2 (ja) * | 2007-08-21 | 2015-06-17 | アッヴィ・インコーポレイテッド | 中枢神経系障害を治療するための医薬組成物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4757151A (en) * | 1985-11-14 | 1988-07-12 | Warner-Lambert Company | 2-substituted-[2-substituted-amino]-N-arylalkyl-3-[indol-3-yl] |
| US4814463A (en) * | 1985-12-31 | 1989-03-21 | Biomeasure, Inc. | CCK antagonists |
| JPH0761992B2 (ja) * | 1987-02-06 | 1995-07-05 | 武田薬品工業株式会社 | 置換アミン誘導体 |
| US4888427A (en) * | 1987-04-07 | 1989-12-19 | University Of Florida | Amino acids containing dihydropyridine ring systems for site-specific delivery of peptides to the brain |
| US4877785A (en) * | 1987-10-01 | 1989-10-31 | G. D. Searle & Co. | Non-peptidyl beta-succinamidoacyl aminodiols as anti-hypertensive agents |
| EP0442878A4 (en) * | 1988-04-05 | 1991-10-23 | Abbott Laboratories | Derivatives of tryptophan as cck antagonists |
| NZ234264A (en) * | 1989-06-29 | 1993-05-26 | Warner Lambert Co | N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives, and pharmaceutical compositions |
| FR2700540B1 (fr) * | 1993-01-15 | 1995-02-17 | Irj | alpha-méthyl-(R)-tryptophyl-arylcycloalkylalkylamides ligands aux récepteurs des gastrines, leur préparation et leur utilisation en thérapeutique. |
-
1991
- 1991-07-12 US US07/726,654 patent/US5244915A/en not_active Expired - Lifetime
- 1991-08-29 CA CA002088996A patent/CA2088996A1/en not_active Abandoned
- 1991-08-29 EP EP91919909A patent/EP0546123A1/en not_active Ceased
- 1991-08-29 JP JP3518049A patent/JPH06502850A/ja active Pending
- 1991-08-29 KR KR1019930700602A patent/KR930702296A/ko not_active Withdrawn
- 1991-08-29 WO PCT/US1991/006177 patent/WO1992004322A1/en not_active Ceased
- 1991-08-29 FI FI930878A patent/FI930878L/fi unknown
- 1991-08-29 AU AU88661/91A patent/AU658377B2/en not_active Ceased
- 1991-08-30 PT PT98828A patent/PT98828A/pt not_active Application Discontinuation
- 1991-08-30 IE IE307891A patent/IE913078A1/en unknown
- 1991-08-30 NZ NZ239612A patent/NZ239612A/en unknown
-
1993
- 1993-04-20 US US08/049,721 patent/US5397788A/en not_active Expired - Fee Related
-
1994
- 1994-12-05 US US08/347,999 patent/US5523306A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US5523306A (en) | 1996-06-04 |
| IE913078A1 (en) | 1992-03-11 |
| JPH06502850A (ja) | 1994-03-31 |
| EP0546123A1 (en) | 1993-06-16 |
| US5244915A (en) | 1993-09-14 |
| FI930878A0 (fi) | 1993-02-26 |
| KR930702296A (ko) | 1993-09-08 |
| CA2088996A1 (en) | 1992-03-01 |
| AU658377B2 (en) | 1995-04-13 |
| US5397788A (en) | 1995-03-14 |
| FI930878A7 (fi) | 1993-04-16 |
| FI930878L (fi) | 1993-04-16 |
| EP0546123A4 (https=) | 1994-04-27 |
| NZ239612A (en) | 1994-02-25 |
| WO1992004322A1 (en) | 1992-03-19 |
| AU8866191A (en) | 1992-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT98828A (pt) | Processo para a preparacao de derivados de aminoacidos ciclizados no terminal-c e de composicoes farmaceuticas que os contem | |
| CA2344707C (en) | N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives | |
| CA2088980C (en) | Pro-drugs for cck antagonists | |
| US5574013A (en) | N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp derivatives | |
| PT98842B (pt) | Processo para a preparacao de derivados de fenilalanina e de fenetilamina n-substituidos com cicloalquilo e policicloalquilo, alfa-substituidos com arilo e heteroarilo e de composicoes farmaceuticas que os contem | |
| US5278316A (en) | N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives | |
| US5244905A (en) | N-substituted cycloalkyl and polycycloalkyl polyhydro-β-carboline-phenylalanine- and phenethylamine derivatives | |
| US5340825A (en) | Pro drugs for CCK antagonists | |
| US5218123A (en) | Didehydrotryptophan derivatives and pharmaceutical use thereof | |
| AU651390C (en) | Novel cholecystokinin antagonists, their preparation and therapeutic use | |
| PT98830A (pt) | Processo para a preparacao de derivados de triptofano (trp) alfa-substituidos n-substituidos com cicloalquilo e policicloalquilo e de composicoes farmaceuticas que os contem |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB1A | Laying open of patent application |
Effective date: 19920319 |
|
| FC3A | Refusal |
Effective date: 19990129 |